The costs of drug abuse consequences: A summary of research findings
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The purpose of this article is to provide researchers, clinicians, and policymakers with a common source of published cost estimates for drug abuse consequences. Across the broad range of potential complications associated with drug abuse, some of the cost elements are specific and directly related to drug abuse per se (e.g., drug treatment costs), while other items may be related to drug abuse (e.g., typical emergency room cost). The results presented here are based on a review of completed and ongoing studies, which include published papers, monographs, conference presentations, working papers, reports, insurance company records, newsletters, and expert judgment. Whenever possible, we report an average cost estimate and the range of available estimates. Each cost element is normalized to 1994 dollars. The results are organized by type of cost and are presented in tabular format so that the findings can be easily understood and used.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Financing and cost of standard and enhanced methadone treatment
Bradley, C. J., French, M. T., & Rachal, J. V. (1994) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(94)90096-5 · Cited by 52
Self-citationCost analysis of training and employment services in methadone treatment
French, M. T., Bradley, C. J., Calingaert, B., Dennis, M. L., & Karuntzos, G. T. (1994) · Evaluation and Program Planning · doi:10.1016/0149-7189(94)90048-5 · Cited by 40
Self-citation
Research works printed but not linked: 39
- Administration for Families and Children, 1993, Streamlined state plan for AFDC, AFC report AFC-1346
- Albers, 1993, Children in foster care: Possible factors affecting permanency planning, Child and Adolescent Social Work Journal, 10, 329, 10.1007/BF00758263 · doi:10.1007/bf00758263
- Anderson, 1992, A sober look at the costs of intoxication, Contemporary Policy Issues, 10, 111, 10.1111/j.1465-7287.1992.tb00230.x · doi:10.1111/j.1465-7287.1992.tb00230.x
- Andrulis, 1995, U.S. hospital care for HIV-infected persons and the role of public and private teaching hospitals: 1988–1991, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 9, 193
- Arno, 1989, Economic and policy implications of early intervention in HIV disease, Journal of the American Medical Association, 262, 1493, 10.1001/jama.1989.03430110083033 · DOI
- Avruch, 1995, Savings achieved by giving WIC benefits to women prenatally, Public Health Reports, 110, 27
- Benedict, 1991, Factors associated with foster care length to stay, Child Welfare, 70, 45
- Bennett, 1992, Medical care costs of intravenous drug users with AIDS in Brooklyn, Journal of Acquired Immune Deficiency Syndromes, 5, 1
- Bleichrodt, 1995, QALYs and HYEs: Under what conditions are they equivalent?, Journal of Health Economics, 14, 17, 10.1016/0167-6296(94)00033-Z · DOI
- Bozzette, 1994, A cost analysis of approved antiretroviral strategies in persons with advanced human immunodeficiency virus disease and zidovudine intolerance, Journal of Acquired Immune Deficiency Syndromes, 7, 355
- Chaikind, 1993, What do we know about the costs of special education? A selected review, The Journal of Special Education, 26, 344, 10.1177/002246699302600402 · doi:10.1177/002246699302600402
- Coleman, 1993, Overview of substance abuse, Primary Care, 20, 1, 10.1016/S0095-4543(21)00361-4 · DOI
- Conviser, 1991, A hospital-based case management program for PWAs in New Jersey, AIDS and Public Policy Journal, 6, 148
- French, 1995, Economic evaluation of drug abuse treatment programs: Methodology and findings, American Journal of Drug and Alcohol Abuse, 21, 111, 10.3109/00952999509095233 · DOI · Paper page
- French, 1996, Health care reforms and managed care for substance abuse services: Findings from eleven case studies, Journal of Public Health Policy, 17, 181, 10.2307/3342697 · DOI
- French, 1996, Estimating the dollar value of health outcomes from drug abuse interventions, Medical Care, 34, 890, 10.1097/00005650-199609000-00003 · DOI · Paper page
- French, 1995, A methodology for evaluating the costs and benefits of employee assistance programs, Journal of Drug Issues, 25, 451, 10.1177/002204269502500213 · DOI
- Grannemann, 1986, Estimating hospital costs: A multiple-output analysis, Journal of Health Economics, 5, 107, 10.1016/0167-6296(86)90001-9 · DOI · Paper page
- Heien, 1989, The economic costs of alcohol abuse: An assessment of current methods and estimates, Journal of Studies on Alcohol, 50, 567, 10.15288/jsa.1989.50.567 · DOI
- Hellinger, 1993, The lifetime cost of treating a person with HIV, Journal of the American Medical Association, 270, 474, 10.1001/jama.1993.03510040078033 · DOI · Paper page
- Hellinger, 1994, AIDS treatment costs during the last months of life: Evidence from the ACSUS, Health Services Research, 29, 569
- Holtgrave, 1995, Threshhold analysis and HIV prevention programs, Medical Decision Making, 15, 311, 10.1177/0272989X9501500402 · DOI
- Hsia, 1995, Pediatric human immunodeficiency virus infection: Recent evidence on the utilization and costs of health services, Archives of Pediatric and Adolescent Medicine, 149, 489, 10.1001/archpedi.1995.02170180019003 · doi:10.1001/archpedi.1995.02170180019003
- Hu, 1981, The application of cost-effectiveness analysis to the evaluation of drug abuse prevention programs: An illustration, Journal of Drug Issues, 11, 125, 10.1177/002204268101100108 · DOI
- Jacobs, 1995, AIDS in correctional facilities: Current status of legal issues critical to policy development, Journal of Criminal Justice, 23, 209, 10.1016/0047-2352(95)00011-E · doi:10.1016/0047-2352(95)00011-e
- Joyce, 1995, The impact of prenatal exposure to cocaine on newborn cost and length of stay, Health Services Research, 30, 341
- Lessard, 1985, Costs and benefits of chemical dependency treatment, Minnesota Medicine, 68, 449
- Long, 1994, The costs and financing of perinatal care in the United States, American Journal of Public Health, 84, 1473, 10.2105/AJPH.84.9.1473 · doi:10.2105/ajph.84.9.1473
- Mann, 1994, Can meta-analysis make policy?, Science, 266, 960, 10.1126/science.7973676 · DOI
- McCormick, 1985, The contribution of low birth weight to infant mortality and childhood morbidity, The New England Journal of Medicine, 312, 82, 10.1056/NEJM198501103120204 · DOI · Paper page
- Miller, 1993, Data watch: Victim costs of violent crime and resulting injuries, Health Affairs, 12, 186, 10.1377/hlthaff.12.4.186 · DOI · Paper page
- Phibbs, 1991, The neonatal costs of maternal cocaine use, Journal of the American Medical Association, 266, 1521, 10.1001/jama.1991.03470110067035 · DOI · Paper page
- Pitts, 1990, Variation in the THC content in illicitly imported cannabis products—1984–1989, Journal of Pharmacy and Pharmacology, 42, 817, 10.1111/j.2042-7158.1990.tb07032.x · doi:10.1111/j.2042-7158.1990.tb07032.x
- Raddiee, 1990, Hospital cost analysis for Nevada, Nevada Review of Business & Economics, 15, 2
- Rajkumar, A.S., & French, M.T. (in press). Drug abuse, crime costs, and the economic benefits of treatment. Journal of Quantitative Criminology.
- Reis, 1991, Costs and benefits of deferred teenage births, Evaluation and Program Planning, 14, 63, 10.1016/0149-7189(91)90040-N · doi:10.1016/0149-7189(91)90040-n
- Schwartz, 1989, What price prematurity?, Family Planning Perspectives, 21, 170, 10.2307/2135808 · DOI
- Van Stelle, 1994, Recidivism to the criminal justice system of substance-abusing offenders diverted into treatment, Crime and Delinquency, 40, 175, 10.1177/0011128794040002003 · DOI
- Zarkin, 1994, A conceptual framework for the economic evaluation of substance abuse interventions, Evaluation and Program Planning, 17, 409, 10.1016/0149-7189(94)90041-8 · DOI
Cited by
Brief Physician Advice for Problem Drinkers: Long-Term Efficacy and Benefit-Cost Analysis
Fleming, M. F., Mundt, M. P., French, M. T., Manwell, L. B., Stauffacher, E. A., & Barry, K. L. (2002) · Alcoholism: Clinical & Experimental Research · doi:10.1097/00000374-200201000-00006 · Cited by 538
Self-citationGuidelines for the psychosocially assisted pharmacological treatment of opioid dependence
Uchtenhagen, A. (2009) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-17408 · Cited by 490
Benefit-Cost Analysis of Brief Physician Advice With Problem Drinkers in Primary Care Settings
Fleming, M. F., Mundt, M. P., French, M. T., Manwell, L. B., Stauffacher, E. A., & Barry, K. L. (2000) · Medical Care · doi:10.1097/00005650-200001000-00003 · Cited by 355
Self-citationThe economic costs of heroin addiction in the United States
Mark, T. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00162-9 · Cited by 271
Risk Factors for Skin and Soft‐Tissue Abscesses among Injection Drug Users: A Case‐Control Study
Murphy, E. L., DeVita, D., Liu, H., Vittinghoff, E., Leung, P., Ciccarone, D. H., & Edlin, B. R. (2001) · Clinical Infectious Diseases · doi:10.1086/320879 · Cited by 262
Metadata
- Authors
- French, M. T., & Martin, R. F.
- Venue
- Journal of Substance Abuse Treatment
- Publisher
- Elsevier BV
- Published
- 1996-11
- Volume
- 13
- Issue
- 6
- Pages
- 453-466
- ISSN
- 0740-5472 (ISSN-L)
- OpenAlex
- W2136621518
- Cited by
- 58
- References
- 2
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 977 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The costs of drug abuse consequences: A summary of research findings. https://app.cochat.ai/papers/10.1016/s0740-5472(96)00128-6
- The paper
- French, M. T., & Martin, R. F. (1996). The costs of drug abuse consequences: A summary of research findings. Journal of Substance Abuse Treatment. https://doi.org/10.1016/s0740-5472(96)00128-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.